The Role of Penis Envy Mushrooms in Personal Development and Healing
goodmoods23
Penis Envy mushrooms offer a gradual, potent trip. However, what sets them apart from other psilocybe cubensis mushrooms is their powerfully heightened visual effects and intense introspective experiences.
Compared to most other strains, Penis Envy shrooms are among the hardest-hitting. Beginners and veterans should be respectful when looking to trip on them.
Penis Envy delivers powerful experiences, perfect for going on a journey of spiritual, emotional, and personal growth.
You can also simply enjoy a trippy experience, where Penis Envy will alter your perception and lead you to a sense of bliss.
Penis Envy mushrooms also offer medical and therapeutic benefits. Many people experience improved mental health, using them for conditions like addiction, depression and eating disorders.
Much like no person is the same, neither are magic mushroom experiences. Taking it slow and being prepared can help ensure your trip is safe and enjoyable.
We’ll unpack everything you need to know about Penis Envy and how it affects you, so you can have a positive and profound experience.
What are Penis Envy mushrooms?
Penis Envy mushrooms are a renowned group of hallucinogenic mushrooms from the Psilocybe cubensis species. They outshine other members of the family (and other psychedelic mushrooms) with their potency, delivering intense mind-altering effects.
Compared to the Golden Teacher strain, which offers consistent and predictable effects, Penis Envy delivers more profound and intense experiences. Blue Meanie, on the other hand, activates faster and offers more powerful effects.
The Penis Envy strain gets its name from its unique shape. Like other psilocybe cubensis strains, its history may date back to prehistoric Europe or Australia1.
This strain also features diverse genetics, with several variants sprouting from its cultivation.
What do Penis Envy shrooms look like?
These mushrooms don’t earn their name from Freud’s penis envy psychology theory, but from their distinctly phallic appearance. They feature a thick stem and bulbous cap, closely resembling a penis.
Aside from their memorable shape, Penis Envy shrooms feature light to dark brown caps. When you handle them, their white stems bruise blue. This effect emphasizes Penis Envy’s strength: the more blue you see, the more psilocybe cubensis there is to oxidize with the air2.
What are Penis Envy’s origins?
Penis Envy originates from a genetic mutation of the Psilocybe cubensis family, which likely emerged around 57 million years ago3. Iconography from northern Australia may depict shamanic use of psychedelic mushrooms from 10,000 BCE4.
Nature played a significant role in the development of the Penis Envy mushroom. However, cultivators who encountered this remarkable strainsought to understand, develop, and refine it.
Many of them discovered these psychedelic mushrooms during America’s explosive counterculture era of the 1960s and 1970s3. After tinkering and experimenting, they birthed an array of exciting Penis Envy variants.
What are Penis Envy’s genetics?
The Penis Envy strain is an offshoot with offshoots. Since mutating from Psilocybe cubensis, it’s continued to sprout variants, either naturally or thanks to cultivator intervention.
Several subtypes of the sought-after Penis Envy mushroom exist, each offering distinct characteristics and effects:
Albino Penis Envy:This strain is smaller and features a pale white stem contrasted by a deep blue-tinged cap.
Penis Envy Number 6: This is a greater spore-producing strain of Penis Envy.
Penis Envy Uncut: This strain is an albino cross with thicker, longer stems.
Trans Penis Envy: This is a hybrid strain with thinner stems and milder effects.
How do Penis Envy mushrooms affect the mind and body?
Penis Envy shrooms deliver psychedelic effects thanks to psilocybe cubensis. This compound metabolizes into psilocin in the human body after consumption5.
Psilocin interacts with receptors like norepinephrine and serotonin in the brain. This reaction results in hallucinogenic experiences, like an altered concept of time and visual perception. It can even induce profound spiritual revelations.
Penis Envy mushroom effects typically take between 30–45 minutes to kick in. Once they do, you can expect an altered physical and psychological state that lasts around six hours6.
Penis Envy’s psychological effects
Psychedelic mushrooms are well-known for causing hallucinations, and Penis Envy shrooms are no exception. You can expect several psychological experiences at a higher intensity7:
Profound introspection: Many people reflect deeply on their innermost thoughts and emotions and experience elevated self-awareness.
Euphoria: People often experience heightened emotional states, leading to a sense of bliss or nirvana.
Vivid hallucinations: Penis Envy mushrooms change the way you perceive reality, showing you patterns, colors, shapes, and distortions. You may even hear sounds or voices that aren’t real.
Penis Envy’s physical effects
The Penis Envy strain can also affect you physically. You may experience the following7:
Altered perception of time: Many people experience time distortion when consuming Penis Envy. You may lose your sense of time and space, blurring or slowing it down.
Disorientation: You may feel less control over your muscles and balance, making it awkward to move your arms and legs properly.
Physical sensations: People often experience tingling like pins and needles or warmth spreading throughout their bodies. You typically feel these sensations in your arms and legs.
The therapeutic and personal development benefits of Penis Envy mushrooms
Psilocybin mushrooms like Penis Envy offer many uses. Until recently, recreation and spiritual exploration were at the forefront, helping people have fun and broaden their understanding of the universe.
Since regulations were relaxed for clinical research, many institutions are studying the medicinal and therapeutic uses of psilocybe cubensis mushrooms like Penis Envy.
Microdosing for personal growth
Taking one or two doses of psilocybe cubensis mushrooms could help rewire the way your brain processes self-reflection and feeling stuck8. This key finding opens up many opportunities for mental and personal growth.
Penis Envy mushrooms are known for their deeply introspective effects. Tied with helping rewire your brain, they could aid in changing your outlook on life and deepen your connectedness with others.
Psilocybin mushrooms may reduce the fear of death, which could influence other fears, helping you confront and overcome things holding you back.
A popular mushroom consumption method is microdosing. It involves self-administering doses too small to produce psychedelic or cognitive-altering effects.
Taking these minuscule doses, between 0.1–0.3 grams of dried mushrooms, can reduce anxiety and depression. They can even lower stress, improve mood, and boost cognitive function9.
Penis Envy mushrooms may help with personal growth. Through introspection, connectedness to the divine, and a reduction in stress and anxiety, navigating your fears, insecurities, and flaws could become much easier.
The therapeutic potential of Penis Envy Mushrooms
The interest in psilocybe cubensis’s medicinal and therapeutic potential kicked off in the 1950s. To meet the research demand, scientists created a synthetic version and focused efforts on boosting its production10.
By increasing the purity, financial efficiency, and yield, researchers could better explore the therapeutic benefits of psilocybe cubensis mushrooms like Penis Envy.
Several studies have taken place, highlighting psilocybe cubensis mushrooms’ potential to treat different disorders:
End-of-life distress: 16 participants with life-threatening cancer took a single dose of psilocybe cubensis. 60–80% saw significant reductions in depression, demoralization, anxiety, death anxiety, and hopelessness after 3–4.5 years11.
Smoking cessation: Longtime smokers, after a controlled psilocybe cubensis therapy session, had an 80% abstinence success rate at six-month follow-ups for psilocybe cubensis-assisted treatment of tobacco addiction12,13,14.
Treatment-resistant depression (TRD) and major depressive disorder (MDD): Psychedelic psilocybe cubensis treatment relieved MDD symptoms in adults. Psilocybin-assisted therapy reduced symptoms of MDD and TRD, with 58% in remission after one year15,16.
Alcohol use disorder (AUD):Research shows that psilocybe cubensis and psychotherapy can help with alcohol addictions. Two treatment sessions reduced heavy drinking days, consumption, and cravings over 32 and 36 weeks17,18.
Cocaine use disorders: Researchers at the University of Alabama at Birmingham (UAB) are running a psilocybe cubensis trial on people with cocaine use disorder. Its goal is to test psilocybe cubensis’s potential to treat their addiction19.
Methamphetamine use disorder: Scientists believe that psilocybe cubensis-assisted therapy could help people quit meth. They’re planning and running four studies to test this theory20.
Non-substance addictions: Psilocybin-assisted therapy can reduce substance use disorders and symptoms of depression. These findings show its potential to aid with non-substance addictions with similar underlying mechanisms21,22.
Alzheimer’s disease:Researchers are investigating psilocybe cubensis’s potential to help with Alzheimer’s symptoms. It could boost cognition and promote neuroplasticity23,24.
Eating disorders: Psilocybin therapy may be able to help with symptoms of anorexia nervosa in women. Among a small, 10-woman study, some saw improvements in their eating disorder25.
Chronic pain: Microdosing psilocybe cubensis could help reduce chronic pain and be effective in pain management. Psilocybin may also alleviate phantom limb pain when paired with mirror visual feedback (MVF) therapy26,27.
Obsessive-compulsive disorder (OCD): Psilocybin-assisted therapy showed promising results in reducing the symptoms of OCD in nine participants. A single dose lowered symptoms for a year in a study on one person with treatment-resistant OCD28,29.
Treatment-resistant bipolar type II depression (BDII): Psilocybin-assisted therapy may help treat BDII. In a trial, 15 participants with BDII took a single synthetic psilocybe cubensis dose and saw significant depressive symptom reductions30.
How to have a good trip on Penis Envy mushrooms
The best way to make your Penis Envy trip safe is by starting with smaller doses. Use a low dose to identify your tolerance and gradually build up with future trips.
Various factors affect Penis Envy potency and how you react. Light exposure, humidity, and soil quality influence the shrooms’ strength during cultivation. Your mental state, metabolism and body weight impact your experience.
A trusted, sober friend or guide and a safe, comfortable environment can improve your trip and reduce potential risks.
Plan your trip out, too. Ensure you drink and eat a light meal before starting. Prepare enough snacks and water to stay fed and hydrated throughout.
You can also enhance your trip by maintaining a positive mindset and emotional state. Magic mushrooms can heighten negative feelings as much as positive ones. Avoid Penis Envy shrooms when you’re feeling down, anxious, or stressed.
Are Penis Envy mushrooms legal?
Understanding the legal risks involved in taking Penis Envy shrooms is also important. It’s essential you’re aware that their legal status differs depending on where you are.
The United States classifies Penis Envy shrooms as a Schedule I substance under the Controlled Substances Act. However, certain states and cities have decriminalized their use depending on the context.
Oregon (where we’re based) and Colorado were the first to legalize medical psilocybe cubensis treatment.
The list of states getting on board with medicinal fungi is growing. Several states and cities, including Washington, New Mexico, and New York, have loosened regulations, too31.
Go deep with Penis Envy mushrooms
Psychonauts recognize Penis Envy mushrooms for their phallic shape and deeply introspective effects. They can take you on a spiritual journey or help you grow as a person.
Penis Envy mushrooms, along with psychotherapy, also help with conditions like addiction, depression, end-of-life distress, and chronic pain.
Regardless of why you’re taking Penis Envy shrooms, ensure you understand their effects and intensity. A good trip requires a positive mindset, reliable companions and a safe environment.
Do you feel ready to go deep into the recesses of your mind and the universe with Penis Envy mushrooms? Then set your intentions and explore our selection of high-quality, responsibly sourced psilocybe cubensis products at Good Moods.
References
Akers, B. P., Ruiz, J. F., Piper, A., & Ruck, C. A. P. (2011). A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms?1. Economic Botany, 65(2), 121–128. https://doi.org/10.1007/s12231-011-9152-5
Lenz, C., Wick, J., Braga, D., García‐Altares, M., Lackner, G., Hertweck, C., Gressler, M., & Hoffmeister, D. (2020). Injury‐Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms. Angewandte Chemie International Edition, 59(4), 1450–1454. https://doi.org/10.1002/anie.201910175
Rootman, J. M., Kiraga, M., Kryskow, P., Harvey, K., Stamets, P., Santos-Brault, E., Kuypers, K. P. C., & Walsh, Z. (2022). Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Scientific Reports, 12(1), 11091. https://doi.org/10.1038/s41598-022-14512-3
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., & McDonald, W. M. (2020). Psychedelics and psychedelic-assisted Psychotherapy. American Journal of Psychiatry, 177(5), 391–410. https://doi.org/10.1176/appi.ajp.2019.19010035
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020). Long-term follow-up of psilocybe cubensis-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology, 34(2), 155–166. https://doi.org/10.1177/0269881119897615
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybe cubensis in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983–992. Sage Journals. https://doi.org/10.1177/0269881114548296
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2016). Long-term follow-up of psilocybe cubensis-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43(1), 55–60. https://doi.org/10.3109/00952990.2016.1170135
Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022). Efficacy and Safety of psilocybe cubensis-assisted Treatment for Major Depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology, 36(2), 151–158. https://doi.org/10.1177/02698811211073759
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2020). Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of Psychopharmacology (Oxford, England), 29(3), 289–299. https://doi.org/10.1177/0269881114565144
Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., Rotrosen, J., Tonigan, J. S., & Worth, L. (2022). Percentage of heavy drinking days following psilocybe cubensis-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder. JAMA Psychiatry, 79(10), 953–962. https://doi.org/10.1001/jamapsychiatry.2022.2096
Brett, J., Knock, E., Korthuis, P. T., Liknaitzky, P., Murnane, K. S., Nicholas, C. R., Patterson, J. C., & Stauffer, C. S. (2023). Exploring psilocybe cubensis-assisted psychotherapy in the treatment of methamphetamine use disorder. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1123424
Kettner, H., Roseman, L., Gazzaley, A., Carhart-Harris, R., & Pasquini, L. (2024, March 8). Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study. Research Square. https://doi.org/10.21203/rs.3.rs-3977169/v1
SARANGI, A., & Akinkunmi, O. (2023). Psychedelics for the Neuropsychiatric Symptoms of Alzheimer’s disease. The American Journal of Geriatric Psychiatry, 31(3), S44–S45. https://doi.org/10.1016/j.jagp.2022.12.201
Peck, S. K., Shao, S., Gruen, T., Yang, K., Babakanian, A., Trim, J., Finn, D. M., & Kaye, W. H. (2023). Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nature Medicine, 29, 1–7. https://doi.org/10.1038/s41591-023-02455-9
Lyes, M., Yang, K. H., Castellanos, J., & Furnish, T. (2022). Microdosing psilocybe cubensis for chronic pain: a case series. Pain, Publish Ahead of Print. https://doi.org/10.1097/j.pain.0000000000002778
Ramachandran, V., Chunharas, C., Marcus, Z., Furnish, T., & Lin, A. (2018). Relief from intractable phantom pain by combining psilocybe cubensis and mirror visual-feedback (MVF). Neurocase, 24(2), 105–110. https://doi.org/10.1080/13554794.2018.1468469
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006). Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry, 67(11), 1735–1740. https://doi.org/10.4088/jcp.v67n1110
Kelmendi, B., Kichuk, S. A., DePalmer, G., Maloney, G., Ching, T. H. W., Belser, A., & Pittenger, C. (2022). Single-dose psilocybe cubensis for treatment-resistant obsessive-compulsive disorder: A case report. Heliyon, 8(12), e12135. https://doi.org/10.1016/j.heliyon.2022.e12135
Aaronson, S. T., van der Vaart, A., Miller, T., LaPratt, J., Swartz, K., Shoultz, A., Lauterbach, M., Sackeim, H. A., & Suppes, T. (2023). Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2023.4685
